2nd Circ. Backs Another Lilly Win In Zyprexa Warning MDL
The Second Circuit on Thursday affirmed a victory for Eli Lilly & Co. in a suit in multidistrict litigation claiming it failed to warn of diabetes risks associated with its antipsychotic...To view the full article, register now.
Already a subscriber? Click here to view full article